These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1488797)

  • 1. HBV--status in professional blood donors in north India.
    Irshad M; Singh YN; Acharya SK
    Trop Gastroenterol; 1992; 13(3):112-4. PubMed ID: 1488797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors.
    Zawde D; Sisay Y
    Ethiop Med J; 1991 Oct; 29(4):175-83. PubMed ID: 1659534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective study of HBsAG carriers in the blood bank of Navarra].
    Medarde A; del Hierro J; Aramburu E; Esquíroz P; Martínez JL
    Rev Med Univ Navarra; 1988; 32(4):209-16. PubMed ID: 3155332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis 'B' virus (HBV) screening in blood banks in Delhi.
    Acharya SK; Dey AB
    Trop Gastroenterol; 1992; 13(3):95. PubMed ID: 1488801
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective study of posttransfusion hepatitis B virus infection.
    Wang D; Tan D; Cao X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):77-9. PubMed ID: 11503032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen--3 years experience.
    Lakshmi V; Vandana K; Rao RR
    Indian J Pathol Microbiol; 1991 Jan; 34(1):43-9. PubMed ID: 1794906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study about seroconversion of HBV NAT screening-positive crowd from blood donors].
    Wang DW; Wang TB; Liu FP; Shi LL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):127-9. PubMed ID: 18574536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors.
    Inci Fisenk B; Us D; Ozcebe OI; Hascelik G
    Scand J Infect Dis; 2005; 37(8):599-604. PubMed ID: 16099770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary?
    Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
    Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.